NEUROCRINE BIOSCIE earnings per share and revenue

NB3 earnings per share for the last quarter are 0.38 CHF whereas the estimation was 0.99 CHF which accounts for -61.75% surprise. Företagets omsättning för samma period uppgår till 464.86 M CHF trots den uppskattade siffran 462.24 M CHF. Estimated earnings per share for the next quarter are 1.03 CHF, and revenue is expected to reach 488.43 M CHF. Also watch annual changes over time to get a bigger picture of NB3 earnings per share and revenue dynamics.